FDA Drug/Biologics Approval BLA 125261 S-103, USTEKINUMAB

FDA Drug/Biologics Approval BLA 125261 S-103, USTEKINUMAB

Regular price $89.00 USD
Regular price Sale price $89.00 USD
Sale Sold out
BLA 125261 S-103
Company: CENTOCOR ORTHO BIOTECH INC
Drug Name: STELARA
Active Ingredients: USTEKINUMAB
Strength: 90MG/1ML
Dosage Form/Route: INJECTABLE; INJECTION
Action Date: 09/25/2009
Marketing Status: Prescription
Submission Classification: ORIG-1
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details